GUARNERI, PATRIZIA
 Distribuzione geografica
Continente #
AS - Asia 2.880
NA - Nord America 1.700
EU - Europa 1.378
SA - Sud America 543
AF - Africa 54
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 3
Totale 6.567
Nazione #
US - Stati Uniti d'America 1.612
SG - Singapore 1.147
IT - Italia 842
CN - Cina 640
BR - Brasile 441
HK - Hong Kong 332
VN - Vietnam 251
FR - Francia 191
NL - Olanda 161
KR - Corea 120
JP - Giappone 111
BD - Bangladesh 86
IN - India 69
GB - Regno Unito 46
CA - Canada 37
AR - Argentina 35
ID - Indonesia 28
DE - Germania 26
MX - Messico 24
FI - Finlandia 21
IL - Israele 19
CO - Colombia 18
EC - Ecuador 18
ZA - Sudafrica 15
VE - Venezuela 13
ES - Italia 12
PL - Polonia 11
SA - Arabia Saudita 11
TR - Turchia 11
IQ - Iraq 10
MA - Marocco 10
UA - Ucraina 9
EG - Egitto 8
RU - Federazione Russa 8
AU - Australia 7
CL - Cile 7
CR - Costa Rica 7
AT - Austria 5
CH - Svizzera 5
LV - Lettonia 5
TH - Thailandia 5
AL - Albania 4
DZ - Algeria 4
JM - Giamaica 4
JO - Giordania 4
LT - Lituania 4
MY - Malesia 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
PY - Paraguay 4
TN - Tunisia 4
UZ - Uzbekistan 4
BG - Bulgaria 3
BY - Bielorussia 3
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
HN - Honduras 3
KZ - Kazakistan 3
PK - Pakistan 3
SE - Svezia 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
AO - Angola 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
GR - Grecia 2
HR - Croazia 2
IE - Irlanda 2
KE - Kenya 2
KG - Kirghizistan 2
LU - Lussemburgo 2
RS - Serbia 2
SV - El Salvador 2
UY - Uruguay 2
AM - Armenia 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BE - Belgio 1
BO - Bolivia 1
BW - Botswana 1
CU - Cuba 1
DJ - Gibuti 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HU - Ungheria 1
IS - Islanda 1
KH - Cambogia 1
LK - Sri Lanka 1
MD - Moldavia 1
NR - Nauru 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
YT - Mayotte 1
Totale 6.563
Città #
Singapore 683
Santa Clara 667
Hong Kong 329
Hefei 294
Lauterbourg 137
Ashburn 132
San Jose 130
Seoul 118
Beijing 100
Ho Chi Minh City 85
Tokyo 80
Milan 74
Hanoi 60
Los Angeles 59
Rome 58
São Paulo 47
New York 41
Dallas 29
Naples 28
Rio de Janeiro 26
Florence 25
Turin 23
Genoa 20
Mumbai 20
Bologna 18
Helsinki 18
Haiphong 17
Minamishinagawa 17
Bengaluru 16
Buffalo 16
Orem 16
Montreal 15
Palermo 14
Bitonto 11
Guayaquil 11
Minamimotomachi 11
Amsterdam 10
Brooklyn 10
Manchester 10
Pietragalla 10
Reggio Calabria 10
Biên Hòa 9
Da Nang 9
Frankfurt am Main 9
London 9
St Louis 9
Chicago 8
Houston 8
Las Vegas 8
Phoenix 8
Riyadh 8
Bari 7
Belo Horizonte 7
Dhaka 7
Mexico City 7
Monmouth Junction 7
New Delhi 7
Toronto 7
Boardman 6
Catania 6
Denver 6
Elk Grove Village 6
Fortaleza 6
Guangzhou 6
Guarulhos 6
Jakarta 6
Johannesburg 6
San José 6
Thái Nguyên 6
Warsaw 6
Alexandria 5
Boston 5
Brasília 5
Cape Town 5
Durham 5
Hải Dương 5
Istanbul 5
Livorno 5
Messina 5
Nuremberg 5
Padua 5
Querétaro 5
Reggio Emilia 5
Riga 5
Riverside 5
Vicenza 5
Zurich 5
Amman 4
Ankara 4
Asunción 4
Atlanta 4
Bangkok 4
Brescia 4
Can Tho 4
Cascina 4
Charlotte 4
Chennai 4
Jacksonville 4
Kingston 4
Nha Trang 4
Totale 3.838
Nome #
null 618
Analisi farmacologiche di nuovi sistemi nanoparticellari per il rilascio del blu di metilene con potenziali effetti nelle malattie neurodegenerative 122
Neuroanatomia - Un approccio semplice e comprensibile 109
Formulations used to treat ocular diseases comprising e.g. macular edema, uveitis, comprise active ingredients incorporated in nanostructured systems 100
Variazioni dell'espressione di VAPB e dei suoi prodotti di clivaggio nei pazienti con Sclerosi Laterale Amiotrofica 97
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. II Report 81
DBI (DIAZEPAM BINDING INHIBITOR) - THE PRECURSOR OF A FAMILY OF ENDOGENOUS MODULATORS OF GABA-A RECEPTOR FUNCTION - HISTORY, PERSPECTIVES, AND CLINICAL IMPLICATIONS 80
CRISPR/Cas9 "CLN8 null" towards a dysfunctional autophagy in CLN8-associated neuronal ceroid lipofuscinosis diseases-ePoster # 4774 78
Mediatori aminoacidici della retina 77
Topical application of choline-calix[4]arene nanocarrier of silibinin reduces retinal damage in a model of Age-Related Macular Disease. 77
null 76
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse. 75
Eye drops of Ch-Cx carrier silibinin inducing protection in a model of Age-related Macular Disease (AMD). 75
A bicistronic vector to study the effect of CLN8/VAPA interaction on cell physiology and eventually the pathology of CLN8-associated NLC diseases 71
CLN8 protein: a post-translation modification and subcellular distribution study for understanding CLN8 physiopathology 71
Neurosteroidogenic pathways toward retinal neurodegeneration and neuroprotection 70
Nanospheres based on PLGA/amphiphilic cyclodextrin assemblies as potential enhancers of Methylene Blue neuroprotective effect 67
The neurosteroid pregnenolone sulfate contributes to neuronal cell death 66
Expression of VAPB cleavage of products in peripheral blood leukocytes and cerebrospinal fluid of patients with sporadic amyotrophic lateral sclerosis 65
NANOSTRUCTURED FORMULATIONS FOR THE DELIVERY OF SILIBININ AND OTHER ACTIVE INGREDIENTS FOR TREATING OCULAR DISEASES 61
Pregnenolone sulfate modulates NMDA receptors, inducing and potentiating acute excitotoxicity in isolated retina 60
Nanostructured formulations for the delivery of silibinin and other active ingredients for treating ocular diseases 59
Low concentrations of silibinin and choline-calixarene or INU-C8-PEG carriers assembling silibinin promote antioxidant and antiapoptotic effects in neuronal and retinal epithelial cells. 59
The estrogenic retina: The potential contribution to healthy aging and age-related neurodegenerative diseases of the retina 59
Facts News & Views Organo Ufficiale della Società Italiana di NeuroPsicoFarmacologia. Numero Speciale 57
Disfunzione autofagica precoce nella malattia da accumulo lisosomiale tipo ceroidolipofuscinosi associata al gene CLN8 57
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with vesicle-associated membrane protein-associated protein A (VAPA), and genotype-phenotype correlations. TELETHON Grant GGP16277 56
Identifying protein partners of CLN8, an ER-resident protein involved in neuronal ceroid lipofuscinosis 55
Studi di biodisponibilità della Silibinina strutturata in nanoparticelle per la terapia di patologie retiniche neurodegenerative 55
Effetti di nuove diketopiperazine in un modello in vivo di Degenerazione Maculare Senile 55
Relazione finale progetto Studio della degenerazione retinica in corso di lipofuscinosi ceroidea neuronale (malattia di Batten) in topi MND , FIRB-MIUR / RBAU01E3SL_001, anno 2006 54
Autophagy and mitophagy in the CLN8mnd mouse, a model of childhood neurodegenerative diseases 54
Iron accumulation and retinal pathology: neuroprotection by diketopiperazines 54
NEUROSTEROIDOGENESIS IN RAT RETINAS 53
Neurosteroid synthesis: an early event in retinal neurodegeneration 53
TRAIL and TRAIL neutralizing antibody in the retina and RPE/choroid of the 3xTg-AD mouse model of Alzheimer disease. 53
Targeting lipids in CLN8-associated NCL diseases: structural and functional interaction of CLN8 with Vesicle-Associated Membrane Protein-associated Protein A (VAPA), and genotype-phenotype correlations 52
Neglected CLN8 protein function in the neuronal ceroid lipofuscinoses (NCLs). 51
A potential interactome map of CLN8 protein involved in the late-infantile form of neuronal ceroid lipofuscinosis. 51
null 51
Different early ER-stress responses in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 50
Effect of uridine of GABA receptors. 49
METHYL MERCURY ENHANCES TRITIUM LABELED DIAZEPAM BINDING IN DIFFERENT AREAS OF THE RAT BRAIN 49
Retinal oxidation and apoptosis in the motor neuron degeneration mouse, a model of neuronal ceroid lipofuscinosis 49
Orphanet - Il portale delle malattie rare e dei farmaci orfani: The CLN8 variant late-infantile neuronal ceroid lipofuscinosis (CLN8-vLINCL): functional aspects of the CLN8 protein and characterization of the degenerative mechanisms . 49
HIPPOCRATES PON02_00355 Regione Sicilia - Sviluppo di Micro e Nano-Tecnologie e Sistemi Avanzati per la Salute dell'uomo. 47
CNR Environment and Health Inter-departmental Project: present knowledge and prospects for future research. 46
Structure specificity of ER stress in the Cln8-mnd mouse model of the late-infantile neuronal ceroid. 46
Does neurosteroidogenesis contribute to neuronal excitotoxicity? 44
null 44
Human neuroblastoma SH-SY5Y cell line: Neurosteroid-producing cell line relying on cytoskeletal organization 44
The role of autophagy in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis. 44
17b-estradiol synthesis in the adult male rat retina. 43
Tackling mechanisms of CLN8 mutations in neuronal ceroid lipofuscinosis (NCLs). 42
The protective role of estrogen-receptor-beta in retinal excitotoxicity. 41
CAMP/PKA-linked phosphorylation and cytoskeletal organization are required for cholesterol transport and neurosteroid synthesis in neuroblastoma SH-SY5Y cells 41
An early impact of ER stress, inflammation and oxidative stress in the CLN8mnd mouse model of neuronal ceroid lipofuscinosis 41
Sustained release of silibinin to the posterior segment of the eye by mucoadhesive NLC 41
Sistemi modello di patologie retiniche e neurodegenerative e strategie per la comprensione, la diagnosi e la terapia. 40
Identification of an antigen related to the sea urchin RNA-binding protein LP54 in mammalian central nervous system. 39
Riunione Annuale CLNet 39
CLN8 interactors: a possible function of the CLN8 protein in the lipid metabolism and autophagy 38
Execution pathways of pregnenolone sulfate-induced retinal apoptosis 37
Tumor necrosis factor-related apoptosis inducing ligand/glucocorticoid-induced TNF receptor ligand redundancy in neurodegenerative processes 37
TARGETING TUMOR NECROSIS FACTOR-RELATED APOPTOSIS-INDUCING LIGAND AMELIORATES RETINAL PATHOLOGY IN A TRIPLE TRANSGENIC MOUSE MODEL OF ALZHEIMER'S DISEASE 36
Retinal oxidation, apoptosis and age- and sex-differences in the mnd mutant mouse, a model of neuronal ceroid lipofuscinosis 36
Retinopatia diabetica sperimentale: ruolo dei gangliosidi. 35
La patogenesi delle varianti CLN8 nelle ceroidolipofuscinosi. 35
Peripheral-type benzodiazepine receptor role in the regulation of steroid and neurosteroid biosynthesis 35
Modelli retinici per le nanotecnologie e il biomonitoraggio ambientale 34
CLN8 and VAPA, a possible protein-protein interaction at the ER for the regulation of lipid metabolism 34
The protective role of Estrogen-Receptor-Beta in retinal excitotoxicity. 33
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration 33
GAMMA-AMINOBUTYRIC-ACID TYPE-A BENZODIAZEPINE RECEPTORS REGULATE RAT RETINA NEUROSTEROIDOGENESIS 33
TNF-alpha and TNF receptor 1 in retinal and optic nerve degeneration of the CLN8 mutant mouse 33
Orphanet - Il portale delle malattie rare e dei farmaci orfani: Biological and genetic variables in the pathogenesis and clinical progression of amyotrophic lateral sclerosis: identification of biomarkers . 33
High vulnerability of estrogen-producing retinal cells to excitotoxic insult: downregulation of P450 aromatase activity 32
PATHOGENIC MECHANISMS IN THE CLN8 FORM OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS. NEW INSIGHTS INTO THE VISUAL LOSS FROM THE CLN8mnd MOUSE MODEL 31
Ruolo degli estrogeni nella neuroprotezione della retina 31
Modulation of neurosteroidogenesis by NMDA receptors is an early event involved in acute excitotoxicity 31
IN VIVO EFFECTS OF 17BETA-ESTRADIOL AND DHT ON THE RAT RETINA: A PROTEOMIC APPROACH 31
Prodotto l anticorpo anti-CLN8, proteina implicata in una patologia neurodegenerativa rara del bambino. 30
Structure specificity of ER stress in the CLN8-MND mouse model of the late-infantile neuronal ceroid lipofuscinosis. 30
DeadEndTM Colorimetric apoptosis detection system for the analysis of retinal apoptosis 30
Mitochondrial oxidative metabolism in motor neuron degeneration (mnd) mouse central nervous system 29
Functional analysis of L-3H Iysine binding to the rat retina. 29
A caspase-3-dependent pathway is predominantly activated by the excitotoxin pregnenolone sulfate and requires early and late cytochrome c release and cell-speci.c caspase-2 activation in the retinal cell death 29
ENDOPLASMIC RETICULUM STRESS AND THE UNFOLDED PROTEIN RESPONSE IN THE Cln8mnd MOUSE MODEL OF NEURONAL CEROID LIPOFUSCINOSES (NCLS) 29
Uridina e complesso recettoriale GABA Benzodiazepine ionoforo. 29
GABA and benzodiazepine receptors in the rat retina: loss of their functional interaction with age. 29
Induction of neurosteroid synthesis by NMDA receptors in isolated rat retina: a potential early event in excitotoxicity 29
Neurosteroidogenic pathways toward retina neurodegeneration or neuroprotection 29
CLN8 and VAP-A, a possible protein-protein interaction at the ER for the regulation of lipid metabolism and with implication in neurodegenerative diseases. 29
TRITIATED L LYSINE BINDING TO RAT RETINAL MEMBRANE II. EFFECT OF KAINIC ACID D L-ALPHA AMINOADIPIC ACID IODOACETIC ACID AND MODIFICATION BY DARK-EXPOSURE 28
Changes in the sensitivity of benzodiazepine and GABA receptors induced by light and dark adaptation 28
Neurosteroids in the retina: neurodegenerative and neuroprotective agents in retinal degeneration. 28
STRUCTURE SPECIFICITY OF ER STRESS IN THE CLN-MND MOUSE MODEL OF THE LATE-INFANTILE NEURONAL CEROID LIPOFUSCINOSIS 28
MERIT - MEdical Research in ITaly" Progetti multilaterali strategici-MIUR - 28
INVOLVEMENT OF p38 AND JNK mapks PATHWAYS IN SUBSTANCE P-INDUCED PRODUCTION OF TNF - BY PERITONEAL MAST CELLS 28
Retinal steroidogenic machinery: expression and activity of P450scc, P450c17, 3bHSD, P450aromatase 28
Totale 5.387
Categoria #
all - tutte 20.254
article - articoli 6.836
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.145
Totale 28.235


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202431 0 0 0 0 0 0 0 0 17 3 5 6
2024/20252.485 14 9 162 120 635 62 29 71 121 151 598 513
2025/20263.775 209 400 342 575 637 128 492 230 250 189 155 168
2026/2027276 192 84 0 0 0 0 0 0 0 0 0 0
Totale 6.567